Feed

Kinder Morgan reported strong Q3 earnings with a record $14.4 billion project backlog, including $13.2 billion in natural gas expansion projects. The company raised its dividend by 2% and saw EPS grow 21% year-over-year. Long-term take-or-pay contracts with creditworthy counterparties are expected to generate approximately $2.5 billion in additional adjusted EBITDA, potentially increasing the company's base EBITDA by at least 37% by 2025.

Ares Capital agreed to acquire MidCap Financial for $2.6 billion in a cash-and-stock deal, paying $10.88 per share (30.1% premium). The merger will expand Ares Capital's portfolio to over $31 billion across 800+ companies, increase core earnings per share, and provide further support for its 10%+ dividend yield. While the deal introduces some risk from MidCap's recent dividend cut and credit weaknesses, it should strengthen Ares Capital's competitive position as a leading BDC.

The article compares Alibaba Group and Target as investment options for 2026. Alibaba offers higher growth (4% average) and better profitability (11.4% operating margin) but faces regulatory risks and a higher valuation (P/E 23.6x).

Target provides lower valuation (P/E 15.4x), steadier profitability (5.5-5.7% operating margin), and domestic stability but slower growth (1.5% average). The analysis suggests Target may be the better choice for many investors due to its more attractive valuation despite Alibaba's stronger growth profile.

The Vanguard Morningstar Growth ETF (VUG) is recommended for young investors seeking higher returns than the S&P 500. With 72% in technology stocks and a 12.1% compound annual return since 2004 (vs. 10.8% for S&P 500), the ETF offers significant long-term wealth potential, though with greater volatility. A $10,000 investment at age 25 could yield over $350,000 more by retirement compared to an S&P 500 index fund.

SpaceX delivered impressive Q3 results with strong growth across its divisions, particularly in its new 'super intelligence' segment which grew 830% year-over-year. The company's connectivity division (Starlink) generated $5.3 billion in revenue with $2.37 billion in operating income.

CEO Elon Musk projects annual recurring revenue could reach $500 billion to $1 trillion by end of 2027. Based on a potential $500 billion revenue valuation at 10x sales, a $5,000 investment could grow to approximately $12,500 by 2028.

Realty Income (O), a REIT known for monthly dividend payments, offers a 5.7% annual dividend yield—over five times higher than the S&P 500 average. A $10,000 investment would purchase approximately 176 shares, generating about $48 monthly or $573 annually in dividend income. The company has raised dividends for 32 consecutive years since going public in 1994.

Hyphenate, formerly Maximor, announced a $45 million Series A funding round led by Nexus Venture Partners. The autonomous finance platform has grown 11x in 12 months with six public companies as customers. Its self-learning AI agents now handle 90% of routine finance work, with customers reporting 75% fewer audit exceptions and 40% expanding within their first year.

aTyr Pharma (Nasdaq: ATYR), a clinical-stage biotechnology company, announced a 1-for-40 reverse stock split effective October 28, 2026, to comply with Nasdaq Capital Market's minimum bid price requirement. The split will reduce outstanding shares from approximately 100.5 million to 2.5 million, with trading resuming on a split-adjusted basis on October 29, 2026 under the same ticker symbol.

MarketWise, Inc. (NASDAQ: MKTW) announced a quarterly cash dividend of $0.45 per share for Class A common stock holders and a $0.25 distribution per unit for MarketWise, LLC unit holders, payable on December 18, 2026. The dividend includes tax distribution payments resulting from the company's corporate structure.

Allegro MicroSystems announced a series of semiconductor products designed to help AI data centers transition to 800V power distribution and 48V cooling architectures. The new portfolio includes enhanced current sensors (ACS37030, ACS37002), an isolated gate driver (AHV85311), and an improved motor driver (A89333) that increase power density, improve energy efficiency, and reduce board space requirements. The company projects its serviceable addressable market for AI data centers will reach $1.7 billion by fiscal 2031.

SoFi raised its 2026 guidance and introduced a bullish 2027 forecast, expecting adjusted net revenue of $6.4 billion (27% YoY growth) and adjusted EPS of $0.90 per share (48% growth). The company posted record Q3 results with 44% revenue growth, added 1.2 million members, and improved credit quality. Trading at ~17x forward earnings for a company with near-50% earnings growth, the author views the stock as undervalued relative to its growth prospects, though risks remain tied to consumer lending exposure.

Tilray Brands stock has plummeted 70% in 2026 and 97% over five years despite generating nearly $1 billion in revenue. While the company has grown through acquisitions in beverages and alcohol, it remains unprofitable with an operating loss of $60.5 million over the trailing 12 months. The analyst argues the stock could fall further due to weak organic growth, continued cash burn, and limited profitability prospects, despite its low valuation of $400 million market cap.

Airbnb and Five Below represent two distinct consumer growth plays with different strengths. Airbnb leads in growth (24.2% avg YoY since 2021) and profitability (19.4% operating margin), while Five Below offers better valuation multiples (P/E 22.0x vs 33.1x) and impressive 22.9% FY2025 revenue growth. The choice depends on whether investors prioritize growth and profitability or value and affordability.

Meta stock has garnered significant attention following the company's recent earnings report and the successful launch of its personal AI agent. Despite reporting strong quarterly results, Meta's stock declined after the earnings announcement, raising questions about whether it represents a buying opportunity for long-term investors.

Elon Musk warned that AI infrastructure financing is deteriorating, predicting 200+ neoclouds will face consolidation and potential failure by 2027. This could trigger delays in GPU purchases and data center construction, causing a broader market downturn. With eight tech giants representing 36% of the S&P 500, a 30% decline in these companies could result in a 10% market correction, particularly affecting the Nasdaq.

Palantir Technologies and RTX Corporation offer two distinct approaches to defense investing through 2030. Palantir, an AI software company serving defense and intelligence agencies, posted 93% revenue growth but trades at a premium P/E of 168.

RTX, a diversified defense contractor with established products and a $340 billion backlog, offers more balanced valuation at P/E of 31 with dividend support. Palantir suits growth-oriented investors, while RTX appeals to those seeking stability and diversification.

As Microsoft, Alphabet, and Amazon report earnings this week, Nvidia investors should closely monitor capital expenditure (capex) trends from these major GPU customers. All three companies have recently increased their infrastructure spending forecasts, driven by strong AI demand. Rising capex signals continued strong demand for Nvidia's chips and systems, while any slowdown would be concerning for Nvidia's near-term outlook.

CTS Corporation reported Q3 2026 sales of $149.6 million, up 5% year-over-year, with net income of $17.8 million (11.9% margin) and diluted EPS of $0.61. The company increased its 2026 guidance, projecting sales of $580-$590 million and adjusted diluted EPS of $2.78-$2.88.

Diversified end-market sales grew 7% and now represent 60% of total sales. The Millar acquisition advances the company's diversification strategy, particularly in the medical market.

Actuate Therapeutics, a clinical-stage biopharmaceutical company, announced the pricing of an underwritten public offering of approximately 30.99 million shares of common stock and 15.49 million warrants at $0.71 per share-warrant set. The offering is expected to raise approximately $11.0 million in gross proceeds, with potential additional proceeds of $7.0 million if warrants are fully exercised. The company plans to use net proceeds for working capital and general corporate purposes.

nVent Electric announced the lease of a 400,000-square-foot manufacturing facility in Goodyear, Arizona to expand production of engineered buildings and prefabricated electrical houses (e-houses). The facility is expected to begin production in mid-2027 and will create over 200 new jobs. This expansion supports growing demand in infrastructure sectors including data centers and power utilities.

CAMP4 Therapeutics announced it received Clinical Trial Application (CTA) approval from European Union regulatory authorities to initiate its Phase 1/2 ASCEND clinical trial of CMP-002 for SYNGAP1-related disorder. This approval follows clearances from the United Kingdom, Australia, and Argentina, expanding the global footprint of the trial.

The company anticipates dosing the first patient in Q4 2026. CMP-002 is designed to increase SYNGAP1 gene expression and restore protein levels in patients with this rare genetic disorder that currently has no approved disease-modifying treatments.

Auburn National Bancorporation (AUBN) reported Q3 2026 net earnings of $2.5 million ($0.72 per share), representing 13% EPS growth compared to Q3 2025. The company demonstrated improved profitability with net interest margin expanding 15 basis points to 3.36%, efficiency ratio improving to 64.8%, and return on assets reaching 0.99%.

Strong credit quality was maintained with nonperforming assets at just 0.02% of total assets. The company paid a $0.27 per share dividend and maintains well-capitalized regulatory ratios.

CareCloud, Inc. (Nasdaq: CCLD) announced the appointment of Mitchell Brie, CHC, as Chief Compliance Officer effective October 21, 2026. Brie, founder of Empower Healthcare & Compliance Partners (acquired by CareCloud in May 2026), will oversee corporate compliance while continuing as President of Empower. The appointment supports CareCloud's compliance growth strategy, which includes proactive compliance services and a planned late Q4 2026 rollout of an AI-powered SaaS compliance offering targeting the company's base of 40,000+ providers.

Nuwellis announced publication of the ULTRA-Peds Registry study in Pediatric Nephrology, evaluating 91 pediatric patients across seven children's hospitals using the Aquadex SmartFlow System. The study demonstrated 87% patient survival rates and 86.5% procedure completion without interruption, with 62% of patients weighing less than 10 kg. These findings support the company's proposed FDA label expansion for Aquadex from patients weighing 20 kg and above to those weighing 5 kg and above, following a successful pre-submission meeting with the FDA earlier in 2026.

Bloom Energy reported exceptional Q3 results with 138% revenue growth to $1.2B and significantly improved profitability, yet its stock has fallen over 40% from its peak. While the company raised full-year guidance to $4.4-4.6B in revenue, concerns about negative free cash flow (-$181M in Q3) and a premium valuation of 65x earnings are weighing on the stock. Despite strong long-term growth prospects in the fuel cell data center market, the analyst suggests waiting for a more attractive valuation before buying.

DoorDash is in talks to acquire Instacart for approximately $17 billion to expand into grocery delivery and compete with Walmart and Amazon. Meta is raising $35 billion through a stock sale to fund its massive AI infrastructure investments, with Nvidia investing $3 billion in the offering.

Brazilian political uncertainty caused selloffs in MercadoLibre and Nu Holdings due to concerns about government spending and currency weakness. Several major companies report earnings this week including Visa, Enphase Energy, and NXP Semiconductors.

Amazon's AWS segment has become the company's primary profit engine, generating 60% of operating income on just 21% of sales, while e-commerce retail contributes less. Despite heavy AI infrastructure spending pushing free cash flow negative, the article suggests Amazon remains a reasonable buy for long-term investors at current valuations (29x forward earnings), though cautious investors should consider starting with smaller positions.

Lucid achieved a rare positive milestone in Q3 2026 when deliveries exceeded production for the first time, suggesting inventory reduction efforts. However, the company remains in a precarious financial position with massive inventory buildup ($1.38 billion), significant cash burn, and a challenging path to profitability. While the inventory drawdown is encouraging, the company must execute a $1.4 billion cash-flow improvement plan to extend its operational runway.

While AI remains Wall Street's hottest trend, select analysts are bearish on two prominent AI stocks. Palantir Technologies faces a potential 59% downside to $80 per share due to unsustainable growth and an extremely high P/S ratio of 82. Tesla could plummet 93% to $24.86 per share, with concerns over unfulfilled promises regarding Full Self-Driving technology and an unjustifiable forward P/E multiple of 172 given its expected low-double-digit growth.

Greenbrier reported $2.5 billion in fiscal 2026 revenue despite macroeconomic headwinds. The company is shifting toward recurring lease income, which grew 55% to $175 million, providing stability during manufacturing cycles.

Fourth-quarter orders reached $600 million for 3,400 railcars, and the owned lease fleet expanded 23% to 21,000 units with 98% utilization. Management projects fiscal 2027 revenue between $2.8-$3.2 billion with operating margins of 7-7.5%.

Community Financial System reported Q3 2026 earnings of $1.21 per share, beating consensus estimates of $1.19, with revenues of $228.3 million exceeding expectations by 0.43%. However, the stock has underperformed the S&P 500 year-to-date, gaining 8.5% versus the market's 12.1%. The company received a Zacks Rank #3 (Hold) rating, suggesting near-term performance in line with the market.

Zacks recommends three top-performing mutual funds for retirement portfolios: American Funds Growth Fund of America R4 (RGAEX) with 11.3% five-year returns, Fidelity Advisor Growth Opportunities A (FAGAX) with 12% returns, and Franklin Templeton SMACS (FQTEX) with 12% returns and a 0.05% expense ratio. All three funds are characterized by low fees, diversification, and strong long-term performance.

Adagene Inc. (Nasdaq: ADAG), a clinical-stage biotechnology company, announced that senior management will participate in a fireside chat and one-on-one meetings at the Guggenheim Securities 3rd Annual Healthcare Innovation Conference on November 9-11, 2026 in Boston. The company is advancing its lead clinical program muzastotug (ADG126), a masked anti-CTLA-4 SAFEbody currently in Phase 1b/2 and Phase 2 studies for microsatellite stable metastatic colorectal cancer in combination with anti-PD-1 therapy.

eSoftware Associates advises defense contractors to conduct thorough access reviews before deploying Microsoft 365 Copilot, ensuring compliance with CMMC Level 2 requirements and proper handling of controlled unclassified information (CUI). The company emphasizes that cloud environment selection (GCC vs. GCC High), user permissions, and sensitivity-label encryption must be properly configured to prevent unauthorized data access through Copilot responses.

Iovance Biotherapeutics announced it will report Q3 2026 financial results on November 5, 2026. The company also presented data at ESMO 2026 showing strong efficacy of its lifileucel TIL cell therapy, with 50% objective response rate in soft tissue sarcomas and 62.5% response rate in combination with pembrolizumab for frontline advanced melanoma, with median overall survival not yet reached after 4+ years of follow-up.

Cullinan Therapeutics announced FDA and Australian regulatory clearance to initiate a Phase 1b/2a clinical trial of velinotamig, a BCMAxCD3 T cell engager, in patients with relapsing and refractory immune thrombocytopenia (ITP) and warm autoimmune hemolytic anemia (wAIHA). The study will evaluate the safety, tolerability, and clinical activity of the subcutaneous treatment designed to deplete antibody-producing plasma cells in these serious autoimmune blood disorders.

Bioventus Inc. announced it will report third quarter fiscal year 2026 financial results on November 2, 2026 after market close, with a management conference call at 4:30 p.m. ET to discuss results and provide a business update. The webcast will be available on the company's investor relations website.

Fortrea (FTRE), a leading global CRO, announced that CEO Anshul Thakral, CFO Jason Knoblauch, and SVP of Investor Relations Tracy Krumme will participate in the Jefferies Global Healthcare Conference in London on November 17, 2026, with a fireside chat and 1x1 meetings scheduled.

Factorial Energy Inc. (Nasdaq: FAC), a solid-state battery technology leader, announced it will release third quarter 2026 financial results on November 10, 2026, followed by a management webcast and conference call at 4:30 PM ET. The company is backed by IQT, Mercedes-Benz, Stellantis, Hyundai, and Kia, and has achieved notable milestones including a drone world record and a Mercedes-Benz test vehicle exceeding 1,200 km range on a single charge.

Neocloud ETF NCLD is down 30% YTD despite surging demand for AI computing capacity. Capital shortages, heavy debt concerns, and investor worries about infrastructure spending timelines are weighing on neocloud stocks like CoreWeave. However, multi-year contracts and an estimated $2.9 trillion in global data center construction through 2028 offer long-term growth potential.

GXO Logistics, the world's largest pure-play contract logistics provider, opened a new state-of-the-art logistics hub in Medini, Malaysia within the Johor-Singapore Special Economic Zone. The facility is designed to support technology and advanced industrial sectors, currently serving a leading semiconductor equipment supplier, and offers strategic positioning for regional supply chain optimization and resilience.

Zedge announced a strategic pivot toward DataSeeds.AI, its enterprise artificial intelligence data initiative, which will serve as the primary growth engine. The company's core marketplace generates cash flow to fund this expansion while leveraging its creator network to produce custom datasets for AI developers. With $20.3 million in cash and zero debt, management plans to invest in sales and technical scaling over fiscal 2027 to execute larger enterprise contracts.

Herc Holdings reported Q3 2026 earnings of $3.91 per share, significantly beating the consensus estimate of $3.08 and representing a 26.95% earnings surprise. The equipment rental supplier also exceeded revenue expectations at $1.36 billion.

Despite strong quarterly results, HRI shares have underperformed the S&P 500 year-to-date, declining 14.3% versus the market's 12.1% gain. The company holds a Zacks Rank #1 (Strong Buy) rating based on favorable earnings estimate revisions.

Royal Caribbean reported Q3 2026 earnings of $6.57 per share, beating consensus estimates of $6.38, with revenues of $5.59 billion slightly exceeding expectations. However, the stock has gained only 0.6% year-to-date versus the S&P 500's 12.1% gain. The company received a Zacks Rank #3 (Hold) rating with mixed estimate revisions, and its industry (Leisure and Recreation Services) ranks in the bottom 39% of sectors.

Travel + Leisure Co. (TNL) reported Q3 2026 earnings of $2.21 per share, beating consensus estimates of $2.04, with revenues of $1.1 billion slightly exceeding expectations. However, the stock has declined 7% year-to-date versus the S&P 500's 12.1% gain. The company received a Zacks Rank #3 (Hold) rating with mixed estimate revisions, and operates in an industry ranked in the bottom 39% of Zacks industries.

Applied Industrial Technologies (AIT) reported quarterly earnings of $2.97 per share, beating consensus estimates of $2.86 and showing a 3.85% earnings surprise. The company posted revenues of $1.29 billion, slightly missing estimates by 0.3%.

AIT has outperformed the S&P 500 by 26.5% year-to-date and holds a Zacks Rank #2 (Buy) rating. However, the Manufacturing - General Industrial industry ranks in the bottom 36% of Zacks industries, which could impact future performance.

Acme United Corporation reported Q3 2026 earnings of $0.8 per share, beating consensus estimates of $0.71, with revenues of $58.01 million exceeding expectations by 4.15%. The company has outperformed the market by 57.7% year-to-date. However, it received a Zacks Rank #3 (Hold) rating due to mixed estimate revisions, and operates in the Consumer Products - Discretionary industry which ranks in the bottom 36% of Zacks industries.

CMS Energy reported Q3 2026 earnings of $1.44 per share, beating consensus estimates of $1.34 and representing a 7.46% surprise. Revenue of $2.18 billion also exceeded expectations by 0.22%.

However, the stock has underperformed the S&P 500 year-to-date, declining 0.5% versus the market's 12.1% gain. The company received a Zacks Rank #3 (Hold) rating with mixed estimate revisions, suggesting near-term performance in line with the market.

The article examines two high-yield dividend stocks: AGNC Investment Corp., a mortgage REIT offering a 16.3% yield but with higher dividend cut risk due to interest rate sensitivity, and Main Street Capital, a BDC with a 5.8% yield and a safer dividend history with no cuts since its 2007 IPO. Both companies have maintained their dividends for over 6 years, though AGNC carries more risk while Main Street demonstrates more stable coverage metrics.

Meta Platforms announced a 2-for-1 stock split scheduled for January 19, 2027, creating a new Class C non-voting stock. The move aims to maintain Mark Zuckerberg's voting control above 60% while enabling the company to raise capital for its massive AI infrastructure investments without diluting his power. Meta plans to spend $135-145 billion on AI capex this year and expects to need hundreds of billions more.

Despite Tesla generating nearly twice SpaceX's quarterly revenue, SpaceX commands a $500 billion higher valuation. In a potential merger, Tesla shareholders could own only 43% of the combined $3.5 trillion company while potentially funding SpaceX's massive AI infrastructure expansion requiring $19.6 billion in quarterly capital expenditures.

Shiba Inu soared 45,278,000% in 2021 but has since lost over 90% of its peak value. While the token theoretically could reach $1 through massive token burning, it would require eliminating 99.99998% of circulating supply—a process that would take hundreds of thousands of years at current burn rates. The lack of organic demand, limited merchant adoption (only 1,242 businesses accept it), and the fact that token burning creates no actual value make a $1 price target in 2027 virtually impossible.

TransUnion reported Q3 2026 earnings of $1.25 per share, beating consensus estimates of $1.21, with revenues of $1.31 billion. However, the stock has underperformed the market by 7.2% year-to-date. The company received a Zacks Rank #4 (Sell) rating due to unfavorable estimate revision trends, suggesting near-term underperformance ahead.

SNDL Inc. reported a quarterly loss of $0.03 per share, missing consensus estimates of $0.02 loss by 50%. Revenues of $170.08 million slightly exceeded expectations but declined from $177.35 million year-over-year.

The stock has underperformed the S&P 500 by 35.6% year-to-date. SNDL received a Zacks Rank #3 (Hold) rating with mixed estimate revisions, suggesting near-term performance in line with the market.

Polaris Inc reported quarterly earnings of $1.08 per share, significantly beating the consensus estimate of $0.62 and representing a 74.19% earnings surprise. Revenue reached $2.04 billion, surpassing estimates by 6.59%.

However, the stock has underperformed the market, declining 12.8% year-to-date compared to the S&P 500's 12.1% gain. The company holds a Zacks Rank #3 (Hold) rating, with mixed estimate revisions suggesting near-term performance in line with the market. The Automotive - Domestic industry ranks in the bottom 16% of Zacks industries.

CenterPoint Energy (CNP) reported Q3 2026 earnings of $0.53 per share, beating consensus estimates of $0.50, with revenues of $2.19 billion exceeding expectations by 1.89%. However, the stock has underperformed the S&P 500 year-to-date, gaining 7.5% versus the market's 12.1%.

The company received a Zacks Rank #3 (Hold) rating with mixed estimate revisions, suggesting near-term performance in line with the market. The Utility - Electric Power industry ranks in the top 39% of sectors.

Provident Financial (PROV) reported quarterly earnings of $0.25 per share, missing the consensus estimate of $0.32 per share, representing a -21.88% earnings surprise. However, revenues of $10.57 million slightly exceeded expectations.

The stock received a Zacks Rank #3 (Hold) rating with mixed estimate revisions. The company's industry (Financial - Savings and Loan) ranks in the bottom 25% of Zacks industries, which could negatively impact future performance.

Centene (CNC) reported Q3 2026 earnings of $0.58 per share, significantly beating the consensus estimate of $0.07, representing a 728.57% surprise. The company posted revenues of $50.65 billion, exceeding estimates by 7.63%.

Despite strong performance, CNC received a Zacks Rank #3 (Hold) rating due to mixed estimate revisions. The Medical - HMOs industry ranks in the top 13% of Zacks industries. Peer Cigna (CI) is expected to report results on November 5.

Armstrong World Industries reported Q3 2026 earnings of $2.26 per share, missing consensus estimates of $2.35, though revenues slightly exceeded expectations. The stock has underperformed the market by 25.9% year-to-date.

With a Zacks Rank #3 (Hold) rating and the Building Products - Miscellaneous industry ranking in the bottom 14% of sectors, the company faces industry-wide challenges. Peer Owens Corning is also expected to report declining earnings.

Anthropic filed its S-1 for a Nasdaq IPO under ticker ANT. The company generated $16.3B in revenue in H1 2026 with 1,300% YoY growth, but reported an $80.7B net loss (mostly non-cash charges).

Claude AI identified concerns including long-term compute commitments through 2045, competition from cloud partners, and founder voting control. Claude recommended caution at higher valuations, suggesting only a small speculative position at $500B valuation (15x P/S), but passing at $1T (31x P/S) or $2T (61x P/S).

Independent Bank (IBCP) reported Q3 2026 earnings of $0.92 per share, beating consensus estimates of $0.86 and surpassing revenue expectations. However, the stock received a Zacks Rank #4 (Sell) rating due to unfavorable estimate revision trends, suggesting near-term underperformance despite strong year-to-date gains of 13.8%.

UPS reported Q3 2026 earnings of $1.69 per share, beating consensus estimates of $1.63, with revenues of $22.85 billion exceeding expectations by 2.70%. However, the stock has underperformed the S&P 500 year-to-date, gaining only 1.1% versus the market's 12.1%. The company received a Zacks Rank #3 (Hold) rating, suggesting near-term performance in line with the market.

Michael Burry, famous for his successful bet against the housing market before the 2008 financial crisis, is now betting against AI stocks by shifting to put options on major players like Micron and Nebius. He believes an AI bubble may burst sooner than expected, citing concerns about the $700 billion infrastructure spending and whether tech companies can monetize these investments. While Wall Street remains bullish on AI stocks, Burry and other investing giants like Ken Griffin have raised concerns about valuation levels and spending sustainability.

Swedish Orphan Biovitrum beat Q3 earnings expectations with $0.71 EPS versus consensus of $0.62, and revenue of $945.87 million surpassed estimates by 4.09%. However, the stock received a Zacks Rank #4 (Sell) rating due to unfavorable estimate revision trends ahead of the earnings release, suggesting near-term underperformance despite strong year-to-date gains of 29.7%.

Ares Capital (ARCC) reported Q3 2026 earnings of $0.46 per share, missing the consensus estimate of $0.48 and falling short of year-ago earnings of $0.50. Revenues of $763 million also missed expectations by 2.2%.

Despite the miss, the stock maintains a Zacks Rank #2 (Buy) rating based on favorable estimate revision trends. The company has underperformed the S&P 500 by 20.1% year-to-date.

Hilton Worldwide Holdings (HLT) reported Q3 2026 earnings of $2.45 per share, beating consensus estimates of $2.36, but revenues of $3.33 billion missed expectations by 1.93%. The stock has gained 22.5% year-to-date, outperforming the S&P 500's 12.1% gain. However, the company received a Zacks Rank #3 (Hold) rating due to mixed estimate revisions, and the Hotels and Motels industry ranks in the bottom 36% of Zacks industries.

Webull (BULL) is positioned as an undervalued fintech alternative to Robinhood, growing faster in revenue (51% YoY) and users (13% YoY) while trading at a lower valuation (P/E under 15 vs. Robinhood's 34). The company is expanding its AI capabilities, seeing strong growth in prediction markets (71% sequential growth), and improving profitability with widening margins. Webull is also committing to $100 million in share buybacks over the next 12 months.

Nautilus Biotechnology announced it will receive up to $6 million as part of a $51.7 million ARPA-H-funded SEEDS consortium led by Buck Institute and Georgetown University. The consortium aims to predict protein misfolding and develop diagnostics and therapeutics for neurodegenerative diseases and cancer. Nautilus will deploy its Voyager Platform to measure proteoforms in Alzheimer's disease and Ewing sarcoma research.

Aclaris Therapeutics announced positive Phase 1b results for its bispecific antibody ATI-052 targeting TSLP and IL-4Rα in atopic dermatitis and asthma. The drug demonstrated rapid and durable improvements in skin symptoms and itch in severe AD patients, with 78% achieving EASI-50 response.

In asthma, a single dose produced rapid improvements in airway inflammation and lung function. The compound showed a favorable safety profile with no conjunctivitis observed. Aclaris plans to prioritize Phase 2b development in eosinophilic esophagitis (EoE) starting early 2027.

Enerflex Ltd. announced the appointment of David Primrose (CFO of Finning International) and Mary Zappone (former CEO of Sundyne) to its Board of Directors, effective October 27, 2026. Primrose was also appointed to the Audit Committee. The appointments follow Fernando Assing's retirement and are part of the company's ongoing board refreshment strategy.

Atour Lifestyle Holdings Limited (NASDAQ: ATAT), a leading Chinese lifestyle group operating hospitality and retail businesses, announced it will release its unaudited Q3 2026 financial results on November 10, 2026, followed by a conference call at 7:00 AM U.S. Eastern time. The company will provide a live webcast and telephone access for investors.

InterDigital won a preliminary injunction against TCL in Brazil regarding HEVC patent infringement. A Rio de Janeiro court adopted an independent expert report supporting InterDigital's position that TCL infringes two patents essential to the HEVC standard and that InterDigital's licensing offers comply with FRAND obligations. TCL is now prohibited from implementing HEVC in devices manufactured, imported, or sold in Brazil.

Nautilus Biotechnology reported Q3 2026 revenue of $0.2 million and net loss of $15.6 million. The company published research in Nature Methods demonstrating its Iterative Mapping technology, shared early oncology proteoform assay data, and announced participation in an ARPA-H-funded SEEDS consortium with up to $6 million in expected funding to measure proteoforms in Alzheimer's disease and cancer research.

Anteris Technologies announced that it will present first 30-day clinical and hemodynamic outcomes for its medium-size DurAVR Transcatheter Heart Valve at the TCT 2026 conference in San Diego. The presentation will showcase results from the ongoing EMBARK study, which has treated over 130 patients with the DurAVR THV since 2021. The company will also feature a live case demonstration of the biomimetic valve technology.

Zacks has added five stocks to its Strong Buy list based on positive earnings estimate revisions over the last 60 days. The selections include Netskope (cybersecurity), Paramount Resources (energy), Iovance Biotherapeutics (biopharmaceutical), CrossAmerica Partners (fuel distribution), and Methode Electronics (mechatronic products).

JPMorgan Chase's asset management division projects Bitcoin will deliver 10% annual returns over the next decade, outperforming U.S. large-cap stocks (7.5%), bonds (5.6%), and gold (5.5%). The bank attributes this to Bitcoin's slowing supply growth relative to global money expansion and its role as a store-of-value asset. However, JPMorgan still considers Bitcoin speculative with 55% volatility and does not formally recommend buying it.

Vanguard Consumer Staples ETF (VDC) and iShares U.S. Consumer Staples ETF (IYK) both offer defensive equity exposure in the consumer staples sector. VDC stands out with a significantly lower 0.09% expense ratio versus IYK's 0.37%, a larger portfolio of 103 holdings, and slightly higher five-year returns ($1,453 vs $1,422 on $1,000 invested).

IYK offers a higher 2.4% dividend yield but with more concentrated holdings of 53 stocks. The article recommends VDC as the more compelling option for long-term investors seeking safer portfolio holdings.

The article compares two REIT ETFs: iShares Select U.S. REIT ETF (ICF), which concentrates on 30 large U.S. real estate companies, and iShares Global REIT ETF (REET), which diversifies across 317 global real estate stocks. While ICF has outperformed historically, REET is recommended as the better long-term buy due to its higher dividend yield (3.6% vs 2.7%), lower expense ratio (0.14% vs 0.32%), and broader diversification while maintaining substantial U.S. exposure.